Matches in Wikidata for { <http://www.wikidata.org/entity/Q37376588> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q37376588 description "article científic" @default.
- Q37376588 description "article scientifique" @default.
- Q37376588 description "articolo scientifico" @default.
- Q37376588 description "artigo científico" @default.
- Q37376588 description "artículu científicu espublizáu en 2009" @default.
- Q37376588 description "bilimsel makale" @default.
- Q37376588 description "scientific article published on 22 January 2009" @default.
- Q37376588 description "vedecký článok" @default.
- Q37376588 description "vetenskaplig artikel" @default.
- Q37376588 description "videnskabelig artikel" @default.
- Q37376588 description "vědecký článek" @default.
- Q37376588 description "wetenschappelijk artikel" @default.
- Q37376588 description "wissenschaftlicher Artikel" @default.
- Q37376588 description "наукова стаття, опублікована в січні 2009" @default.
- Q37376588 description "научни чланак" @default.
- Q37376588 description "مقالة علمية نشرت في 22 يناير 2009" @default.
- Q37376588 name "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 name "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 name "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 type Item @default.
- Q37376588 label "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 label "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 label "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 prefLabel "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 prefLabel "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 prefLabel "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 P1433 Q37376588-2727726E-F813-4AD8-8E37-D8A1BEE81AC3 @default.
- Q37376588 P1476 Q37376588-17948E6E-3142-4CE2-8261-5B241E7E9CF0 @default.
- Q37376588 P2093 Q37376588-30F386E0-3AAE-477A-A228-0A5CBF14117C @default.
- Q37376588 P2093 Q37376588-63DBCB67-4A98-4551-8722-65E8D3A6C35F @default.
- Q37376588 P2093 Q37376588-A447A60B-BC96-47DB-87C8-A417C199624D @default.
- Q37376588 P2093 Q37376588-E2FED789-12D2-455C-9D43-0E4CA6EFB32C @default.
- Q37376588 P2093 Q37376588-F10605F8-1BBA-43ED-A1BD-78AE0A0C23B2 @default.
- Q37376588 P2093 Q37376588-FC2772B1-752D-42E2-9526-51642B3F735C @default.
- Q37376588 P304 Q37376588-1204253D-D9AA-47CC-90E0-6E7979E41527 @default.
- Q37376588 P31 Q37376588-5b8dc8be-15c3-4a7c-8785-474c3f866317 @default.
- Q37376588 P31 Q37376588-DF9A11D1-DD31-400F-94CA-BBA53560F79A @default.
- Q37376588 P356 Q37376588-28FEC75D-F63D-4D75-B368-CF9957F95EB6 @default.
- Q37376588 P433 Q37376588-36380510-A855-4290-9AA5-9A91FE3FF9CD @default.
- Q37376588 P478 Q37376588-A8C4E48A-ECFC-4CEE-8D0F-696AC25620A9 @default.
- Q37376588 P577 Q37376588-12778599-C671-4601-B699-D73683FF1E98 @default.
- Q37376588 P698 Q37376588-11C8C5B2-3CFC-4F45-838B-D03BB6CA354C @default.
- Q37376588 P921 Q37376588-32794582-DA8F-43AA-87D9-E3B72C10B560 @default.
- Q37376588 P921 Q37376588-80CCD9A1-C503-4C47-B06C-21F04B7D6784 @default.
- Q37376588 P921 Q37376588-8C3782D6-CD25-4AD6-81A5-FF3816101C90 @default.
- Q37376588 P921 Q37376588-A0FFC090-468A-438A-AABD-BF4C081745D4 @default.
- Q37376588 P356 J.LEUKRES.2008.11.027 @default.
- Q37376588 P698 19167064 @default.
- Q37376588 P1433 Q15716445 @default.
- Q37376588 P1476 "Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature" @default.
- Q37376588 P2093 "Antonello Sica" @default.
- Q37376588 P2093 "Maria Celentano" @default.
- Q37376588 P2093 "Maria Giovanna Ferrara" @default.
- Q37376588 P2093 "Milena Coppola" @default.
- Q37376588 P2093 "Salvatore Guastafierro" @default.
- Q37376588 P2093 "Umberto Falcone" @default.
- Q37376588 P304 "1079-1081" @default.
- Q37376588 P31 Q13442814 @default.
- Q37376588 P31 Q7318358 @default.
- Q37376588 P356 "10.1016/J.LEUKRES.2008.11.027" @default.
- Q37376588 P433 "8" @default.
- Q37376588 P478 "33" @default.
- Q37376588 P577 "2009-01-22T00:00:00Z" @default.
- Q37376588 P698 "19167064" @default.
- Q37376588 P921 Q177094 @default.
- Q37376588 P921 Q2782326 @default.
- Q37376588 P921 Q29496 @default.
- Q37376588 P921 Q729735 @default.